82 results
8-K
EX-4.3
SILO
SILO Pharma Inc
6 Jun 24
Silo Pharma Announces $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
4:52pm
to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except
8-K
EX-4.2
SILO
SILO Pharma Inc
6 Jun 24
Silo Pharma Announces $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
4:52pm
.
Section 5. Miscellaneous.
a) No Rights as Stockholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting … rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
8-K
EX-4.1
SILO
SILO Pharma Inc
6 Jun 24
Silo Pharma Announces $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
4:52pm
does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth
424B5
SILO
SILO Pharma Inc
6 Jun 24
Prospectus supplement for primary offering
6:07am
of a Pre-Funded Warrant does not have the rights or privileges of a holder of our common stock, including any voting rights, until the holder exercises … of the Unregistered Warrants do not have the rights or privileges of holders of our common stock, including any voting rights, until they exercise
S-3/A
EX-5.1
93j807 kbyn3bttun
25 Jan 24
Shelf registration (amended)
5:29pm
S-3
EX-5.1
gjd448lm7ac04a
23 Jan 24
Shelf registration
5:01pm
S-3
jtfos6wj0y7o
23 Jan 24
Shelf registration
5:01pm
8-K12B
EX-4.1
ipzc wymwhq
20 Dec 23
Notification of registration of securities
4:58pm
8-K12B
EX-3.4
0as 7cnogfq8
20 Dec 23
Notification of registration of securities
4:58pm
424B4
zdq4owhh1z 4e49w
28 Sep 22
Prospectus supplement with pricing info
4:34pm